SCHEMBL24718425

SCHEMBL24718425

COC(=O)c1ccccc1CN1CC(NC(=O)c2cc(C)ccc2O)CC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 1/20 0.43
▸ TSHR P16473 3/20 0.38
▸ MAPK10 P53779 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ RECQL P46063 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ NOX4 Q9NPH5 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718655 0.90 BRD4 (0.42) SIRT1TP53ALDH1A1KDM4EBRD4
SCHEMBL24718283 0.87 MEN1 (0.45) TSHRSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL24718415 0.84 TP53 (0.49) SIRT1TP53ALDH1A1KDM4ENPSR1
SCHEMBL24718290 0.81 TSHR (0.45) TSHRALDH1A1NPSR1MEN1KMT2A
SCHEMBL24719136 0.79 CCR2 (0.40) SIRT1KMT2ARAB9A
SCHEMBL24718657 0.77 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4ELMNAMEN1
SCHEMBL24719112 0.77 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4ELMNAMEN1
SCHEMBL24719133 0.77 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4ELMNAMEN1
SCHEMBL24718823 0.76 P2RX1 (0.45) SMN1; SMN2TP53ALDH1A1MEN1KMT2A
SCHEMBL24718430 0.76 P2RX1 (0.45) SMN1; SMN2TP53ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 SIRT1 864/4885TSHR 3782/4885MAPK10 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback